Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
33.72
-0.02 (-0.06%)
Mar 28, 2024, 2:10 PM EDT - Market open

Supernus Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2010
Cash & Equivalents
75.0593.12203.43288.64181.38192.25100.366.433.536.4
Upgrade
Short-Term Investments
179.82368.21136.25133.89165.69163.7739.7423.7228.6937.94
Upgrade
Cash & Cash Equivalents
254.87461.33339.68422.53347.07356.02140.0490.1262.1974.34
Upgrade
Cash Growth
-44.75%35.81%-19.61%21.74%-2.51%154.23%55.39%44.91%-16.34%-9.56%
Upgrade
Receivables
144.16165.5148.93140.8887.33102.9265.5941.5325.9117.27
Upgrade
Inventory
77.4191.5485.9648.3326.6325.6616.316.812.5913.44
Upgrade
Other Current Assets
16.6815.7827.0218.6811.618.896.522.965.263.68
Upgrade
Total Current Assets
493.11734.15601.59630.42472.64493.49228.45151.4105.95108.73
Upgrade
Property, Plant & Equipment
13.5315.1716.9637.8217.074.15.124.343.872.45
Upgrade
Long-Term Investments
16.6293.9119.17350.36591.77418.8133.6475.4155.0119.82
Upgrade
Goodwill and Intangibles
716.91819.48902.21442.2524.8431.3736.0236.350.980.23
Upgrade
Other Long-Term Assets
37.5139.8149.2343.2553.9630.0621.2342.0622.825.57
Upgrade
Total Long-Term Assets
784.56968.361,088873.69687.64484.32196.01158.1682.6828.06
Upgrade
Total Assets
1,2781,7031,6891,5041,160977.81424.46309.57188.63136.78
Upgrade
Accounts Payable
79.5796.34117.6878.9349.713.26.848.064.311.86
Upgrade
Deferred Revenue
0000001.441.711.571.42
Upgrade
Current Debt
0401.9700000000
Upgrade
Other Current Liabilities
210.63189.65197.7166.17110.87158.16114.7270.9851.0524.84
Upgrade
Total Current Liabilities
290.2687.96315.38245.11160.59161.3512380.7456.9328.12
Upgrade
Long-Term Debt
33.236420.55390.33375.61329.4604.177.0926.22
Upgrade
Other Long-Term Liabilities
32.7792.35137.37123.8128.6633.9733.9832.9136.641.74
Upgrade
Total Long-Term Liabilities
65.96128.35557.92514.14404.27363.4433.9837.0743.6967.96
Upgrade
Total Liabilities
356.16816.3873.3759.24564.85524.79156.98117.81100.6296.09
Upgrade
Total Debt
33.2437.97420.55390.33375.61329.4604.177.0926.22
Upgrade
Debt Growth
-92.42%4.14%7.74%3.92%14.01%---41.21%-72.98%-23.75%
Upgrade
Retained Earnings
482.56481.25379.92326.5199.5586.49-26.82-84.29-175.51-189.45
Upgrade
Comprehensive Income
-0.59-3.211.548.987.42-3.16-0.75-0.13-0.49-0.15
Upgrade
Shareholders' Equity
921.52886.2815.85744.86595.43453.02267.48191.7688.0140.7
Upgrade
Net Cash / Debt
221.6823.37-80.8732.2-28.5426.56140.0485.9655.1148.11
Upgrade
Net Cash / Debt Growth
848.64%-----81.04%62.92%55.99%14.53%0.66%
Upgrade
Net Cash Per Share
3.990.38-1.490.60-0.530.492.631.661.081.14
Upgrade
Working Capital
202.9246.19286.21385.31312.06332.13105.4570.6649.0180.6
Upgrade
Book Value Per Share
16.9016.5115.3714.1611.368.715.273.881.850.96
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).